Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 1127 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Prescribing gliptins: Enthusiasm should be coupled with caution

Garg M K, Kharb Sandeep, Pandit Aditi

Year : 2012| Volume: 16| Issue : 2 | Page no: 324-325

   This article has been cited by
1 The paradox of dipeptidyl peptidase IV inhibition in enterocytic differentiation and epithelial-mesenchymal transition in rat cholestatic sepsis
Doaa A. Zaky,Dalia M. Abouelfadl,Noha N. Nassar,Dalaal M. Abdallah,Muhammad Y. Al-Shorbagy
Toxicology and Applied Pharmacology. 2020; 394: 114956
[Pubmed]  [Google Scholar] [DOI]
2 The emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease
Hai Zou,Ning Zhu,Shengqing Li
Expert Opinion on Therapeutic Targets. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Recent Approaches to Medicinal Chemistry and Therapeutic Potential of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Bhumika D. Patel,Manjunath D. Ghate
European Journal of Medicinal Chemistry. 2014;
[Pubmed]  [Google Scholar] [DOI]
4 DPP-4 inhibitors: a patent review (2012 2014)
Roberto Costante,Azzurra Stefanucci,Simone Carradori,Ettore Novellino,Adriano Mollica
Expert Opinion on Therapeutic Patents. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article